These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V. Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119 [Abstract] [Full Text] [Related]
5. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma. Mori N, Ohwashi M, Yoshinaga K, Mitsuhashi K, Tanaka N, Teramura M, Okada M, Shiseki M, Tanaka J, Motoji T. PLoS One; 2013 Apr; 8(11):e80088. PubMed ID: 24224040 [Abstract] [Full Text] [Related]
6. Secretory piece and IgA deficiency in a patient with Waldenstrom's macroglobulinemia. Nussinson E, Lahav M, Berebi A, Estrov Z, Zur S, Resnitzky P. Am J Gastroenterol; 1986 Oct; 81(10):995-8. PubMed ID: 3094364 [Abstract] [Full Text] [Related]
11. Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgA. Tursz T, Brouet JC, Flandrin G, Danon F, Clauvel JP, Seligmann M. Am J Med; 1977 Oct; 63(4):499-502. PubMed ID: 410294 [Abstract] [Full Text] [Related]
12. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report. Barnes M, Sharma P, Kumar V, Kaell A, LiPera W. J Med Case Rep; 2020 Jul 13; 14(1):98. PubMed ID: 32654665 [Abstract] [Full Text] [Related]
13. Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis. Merlini G, Sarosiek S, Benevolo G, Cao X, Dimopoulos M, Garcia-Sanz R, Gatt ME, Fernandez de Larrea C, San-Miguel J, Treon SP, Minnema MC. Semin Hematol; 2023 Mar 13; 60(2):113-117. PubMed ID: 37099030 [Abstract] [Full Text] [Related]
14. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report. D'Aveni-Piney M, Divoux M, Busby-Venner H, Muller M, Broséus J, Feugier P. J Med Case Rep; 2018 Jun 12; 12(1):164. PubMed ID: 29890999 [Abstract] [Full Text] [Related]
18. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA. Semin Oncol; 2003 Apr 12; 30(2):110-5. PubMed ID: 12720118 [Abstract] [Full Text] [Related]
19. Spectral-domain optical coherence tomography of retinal vessels in Waldenström's macroglobulinemia. Willerslev A, Larsen M, Rothenbuehler SP, Sørensen TL, Hammer T, Paques M, Munch IC. Acta Ophthalmol; 2020 Mar 12; 98(2):153-157. PubMed ID: 31423759 [Abstract] [Full Text] [Related]
20. Four brothers with Waldenstrom's macroglobulinemia. Renier G, Ifrah N, Chevailler A, Saint-Andre JP, Boasson M, Hurez D. Cancer; 1989 Oct 01; 64(7):1554-9. PubMed ID: 2505923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]